Bupa health assessments are the UK's best-known private health checks. They include physical measurements, ECG, and a doctor consultation alongside 30 to 40 blood markers. That clinical experience has genuine value. But the blood panel is the weakest component. A comprehensive private test like the TrueVitals Ultimate covers 114 blood biomarkers for £349 — roughly 3 times the blood depth at half the mid-tier Bupa price. Here is an honest comparison of what each option offers and what each misses.
We're a blood testing company. Bupa is a clinical assessment provider. There are things Bupa offers that a blood test physically cannot replicate.
The clinical assessment components are strong. The blood panel is where Bupa falls short. A mid-tier Bupa assessment (£500-700) typically includes 30 to 40 blood markers. Here is what those 30 to 40 markers usually cover, and what they leave out.
The markers in the right column are the ones that detect insulin resistance years before diabetes, identify cardiovascular risk more accurately than standard cholesterol, catch autoimmune thyroid disease before symptoms appear, reveal hormonal decline behind fatigue and weight gain, and screen immune function. They are the highest-value markers in preventive medicine, and Bupa's blood panel excludes most of them.
A Bupa assessment and a comprehensive blood test are not competing products. They are complementary. Each covers what the other misses.
Annually: a comprehensive blood test (£349 for 114 markers or £799 for 200+) for metabolic, hormonal, thyroid, cardiovascular, and nutritional depth. This captures the changes that happen between physical assessments and provides the data-rich baseline that makes each subsequent test more informative.
Every 2 to 3 years: a Bupa or Nuffield assessment (£500-700+) for the ECG, hearing, vision, body composition, and face-to-face doctor consultation. These physical measurements change more slowly than blood markers and don't need annual repetition for most people.
Total annual cost: £349 for a comprehensive blood test plus £200-300 per year if you amortise a £600 Bupa assessment over 2 to 3 years. That's roughly £550 to £650 per year for the most thorough health monitoring available in the UK, combining physical assessment depth with blood testing depth. Neither alone provides the full picture.
Bupa pricing from The Vesey, GoingPrivateUK, and Bupa.co.uk (July 2026). Exact pricing varies by location, tier, and corporate arrangements. TrueVitals pricing as of August 2026. Clinic phlebotomy +£19, at-home +£39.
The TrueVitals Ultimate panel tests 114 biomarkers for £349. That's roughly 3 times the blood depth of a mid-tier Bupa assessment at half the price. AI cross-system analysis. Medical review. Results in 48 hours.
Your employer offers it as a benefit. Take it. It's free, it's thorough within its scope, and the physical measurements have genuine value. Layer a comprehensive blood test on top if you want the depth Bupa doesn't cover.
You want a face-to-face doctor to explain your results. The in-person consultation is something a blood-only test does not replicate. If having a doctor sit with you and talk through each finding is important to you, Bupa delivers that experience well.
You want an ECG or physical measurements. Heart rhythm, hearing, vision, body composition, lung function. These are clinical measurements that blood tests cannot provide. If your family history includes arrhythmia, heart failure, or sudden cardiac events, an ECG matters.
You value the reassurance of a well-known brand. Bupa is the UK's most trusted private health brand. If that brand trust is part of the value for you, it's a legitimate factor. Not everything is about biomarker counts and cost-per-marker ratios.
Bupa's results come as a written report from the doctor who conducted your assessment. It summarises findings, flags concerns, and makes recommendations. For 30 to 40 markers, this individual-marker review works well. A doctor can discuss each finding in context.
A comprehensive panel with 114+ markers requires a different approach. No doctor can meaningfully review 114 markers in a 30-minute consultation. The interactions between markers (low Free T3 alongside rising fasting insulin alongside declining testosterone alongside elevated hs-CRP) need algorithmic pattern recognition that processes thousands of potential interactions simultaneously. That's what AI cross-system analysis provides. The AI handles the analytical depth. A medical professional reviews the output for clinical accuracy. The result is a 30+ page report that explains which systems are driving which symptoms, and what to do about each one.
They're different tools for different depths. Bupa's approach suits a narrower panel. AI-powered analysis suits a comprehensive one. See what the report looks like.
114 biomarkers including everything Bupa tests plus advanced cardiovascular, full hormones, metabolic depth, immunoglobulins, and tumour markers. AI cross-system analysis. Medical review. Results in 48 hours.
.png)